Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma

Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma

ObjectiveThe emergence of multi-drug resistance (MDR) in esophageal carcinoma has severely affected the effect of chemotherapy and shortened the survival of patients. To this end, we intend to develop a biomimetic nano-targeting drug modified by cancer cell membrane, and investigate its therapeutic...

Full description

Bibliographic Details
Main Authors: Yi Gao, Yue Zhu, Xiaopeng Xu, Fangjun Wang, Weidong Shen, Xia Leng, Jiyi Zhao, Bingtuan Liu, Yangyun Wang, Pengfei Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
esophageal carcinoma
multidrug resistant
homologous targeting
doxorubicin
curcumin
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.688070/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2021.688070/full

Similar Items